Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cell Counting Market Size, Share, and Trends - Global Forecast 2026-2032 | AI-Enabled Automation and Cell Therapy Demand Drive 8.45% CAGR Toward USD 14.90 Billion by 2032

globenewswire.com
ABT Abbott Laboratories is listed as a company profile in a report on the cell counting market. The article does not provide specific sentiment towards the company, but its inclusion suggests relevance to the market. A Agilent Technologies, Inc. is mentioned as a company profile in the context of the cell counting market. The article does not offer specific sentiment but implies its participation in this growing sector. BKR Beckman Coulter, Inc. is listed among company profiles relevant to the cell counting market. The article does not express a specific sentiment but indicates the company's presence in this industry. BDX Becton, Dickinson and Company is included in the company profiles section of the cell counting market report. No specific sentiment is expressed, but its mention suggests involvement in the sector. BIO Bio-Rad Laboratories Inc. is listed as a company profile within the cell counting market research. The article does not provide explicit sentiment but its inclusion points to its role in the market. COO Corning Incorporated is mentioned as a company profile in the cell counting market report. The article does not convey specific sentiment but its inclusion suggests relevance to the industry. DHR Danaher Corporation is listed among the company profiles in the cell counting market analysis. The article does not offer specific sentiment but its mention implies its business activities in this sector. LH Laboratory Corporation of America Holdings is mentioned as a company profile in the cell counting market report. The article does not provide specific sentiment but its inclusion suggests relevance to the market. MRK Merck KGaA is listed as a company profile in the cell counting market report. The article does not provide specific sentiment, but its inclusion suggests relevance to the market. OLN Olin Corporation is listed as a company profile in the cell counting market report. The article does not provide specific sentiment, but its inclusion suggests relevance to the market. RIVN Rivian Automotive, Inc. is mentioned as a company profile in the cell counting market report. The article does not provide specific sentiment but its inclusion suggests relevance to the market. SNPS Synopsys, Inc. is mentioned as a company profile in the cell counting market report. The article does not provide specific sentiment but its inclusion suggests relevance to the market. SYK Stryker Corporation is listed as a company profile in the cell counting market report. The article does not provide specific sentiment, but its inclusion suggests relevance to the market. TMO Thermo Fisher Scientific Inc. is listed as a company profile in the cell counting market report. The article does not provide specific sentiment, but its inclusion suggests relevance to the market.

Cell Counting Market Size, Share, and Trends - Global Forecast 2026-2032 | AI-Enabled Automation and Cell Therapy Demand Drive 8.45% CAGR Toward USD 14.90 Billion by 2032 Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Cell Counting Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The Cell Counting Market research report provides a comprehensive assessment of the technologies, applications, growth drivers, and regional dynamics shaping this essential life sciences sector. The market is projected to reach USD 9.11 billion in 2026 and expand at a CAGR of 8.45% to USD 14.90 billion by 2032.

Cell counting supports critical workflows across clinical diagnostics, bioprocessing, immunology, oncology, cell therapy, microbiology, and drug discovery. Demand is rising alongside biologics production, vaccine development, regenerative medicine, and routine hematology requirements for accurate cell concentration, viability, and phenotype measurement.

Market Transformation and Growth Drivers

Laboratories are transitioning from manual hemocytometers to automated cell counters, flow cytometry, image-based analysis, validated consumables, and software-enabled platforms. Automation reduces operator variability, increases throughput, and improves documentation in quality-controlled environments.

Additional market momentum comes from:

The analysis enables decision-makers to align product development and investment plans with high-growth applications while identifying risks associated with validation, integration, and regulatory requirements.

Artificial Intelligence and Advanced Analytics

Artificial intelligence is improving image segmentation, debris exclusion, morphology classification, viability assessment, and anomaly detection. AI-assisted analysis is particularly valuable for clumped, low-contrast, or heterogeneous samples where conventional threshold-based counting may be less reliable.

In regulated bioprocessing and clinical research, AI also supports automated audit trails, predictive maintenance, workflow standardization, and stronger data integrity. The most valuable applications complement validated laboratory methods while preserving scientific oversight, traceability, and compliance.

Regional Market Insights

Country- and region-level insights support market entry planning by highlighting where premium automated systems, modular platforms, or consumable-efficient solutions are most likely to gain traction.

Strategic Group and Country Opportunities

ASEAN markets are strengthening biomedical research, hospital networks, and regional manufacturing, with Singapore serving as a hub for translational medicine and quality systems. GCC countries are investing in precision medicine and health system modernization, while BRICS markets offer scale through large patient populations, vaccine manufacturing, and expanding domestic biopharma capacity.

The United States remains the largest demand center, while China is scaling biomanufacturing and oncology research. India benefits from high diagnostics volumes, vaccines, biosimilars, and private laboratory expansion. Japan emphasizes regenerative medicine and precision instrumentation, while South Korea combines biopharma investment with advanced hospital infrastructure.

Actionable Priorities for Industry Leaders

These insights strengthen competitive positioning by helping suppliers prioritize partnerships, portfolio investments, and service models suited to mature and emerging markets.

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Counting Market, by Product Type

7.1. Introduction

7.2. Consumables & Accessories

7.2.1. Counting Chambers

7.2.2. Microscope Slides

7.2.3. Reagent Kits

7.3. Instruments

7.3.1. Automated Cell Counters

7.3.2. Flow Cytometers

7.3.3. Hemocytometer

7.3.4. Imaging-Based Cell Counters

7.3.5. Microscopes

7.3.6. Spectrophotometers

8. Cell Counting Market, by Technology

8.1. Introduction

8.2. Machine Learning

8.3. Microfluidic Technologies

8.4. Optical Counting Techniques

9. Cell Counting Market, by Cell Type

9.1. Introduction

9.2. Bacterial Cells

9.3. Blood Cells

9.4. Mammalian Cells

9.5. Primary Cells

9.6. Stem Cells

9.7. Yeast Cells

10. Cell Counting Market, by Application

10.1. Introduction

10.2. Biological Research

10.3. Clinical Diagnostics

10.4. Drug Discovery & Development

10.5. Stem Cell Research

11. Cell Counting Market, by End User

11.1. Introduction

11.2. Academic & Research Institutes

11.3. Contract Research Organizations

11.4. Hospitals & Clinical Laboratories

11.5. Pharma & Biotech Companies

12. Cell Counting Market, by Organization Size

12.1. Introduction

12.2. Large Organizations

12.3. Small & Medium-sized Enterprises

13. Cell Counting Market, by Region

13.1. Introduction

13.2. Asia-Pacific

13.3. North America

13.4. Latin America

13.5. Europe

13.6. Middle East

13.7. Africa

14. Cell Counting Market, by Group

14.1. Introduction

14.2. ASEAN

14.3. GCC

14.4. European Union

14.5. BRICS

14.6. G7

14.7. NATO

15. Cell Counting Market, by Country

15.1. Introduction

15.2. United States

15.3. China

15.4. Germany

15.5. India

15.6. Japan

15.7. Canada

15.8. United Kingdom

15.9. Russia

15.10. Brazil

15.11. Italy

15.12. Mexico

15.13. France

15.14. Spain

15.15. Australia

15.16. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2025

16.2. Market Concentration Analysis, 2025

16.2.1. Concentration Ratio (CR)

16.2.2. Herfindahl Hirschman Index (HHI)

16.3. Recent Developments & Impact Analysis, 2025

16.4. Product Portfolio Analysis, 2025

16.5. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Abbott Laboratories

17.2. Advin Health Care

17.3. Agilent Technologies, Inc.

17.4. Beckman Coulter, Inc.

17.5. Becton, Dickinson and Company

17.6. Bio-Rad Laboratories Inc.

17.7. Boule Diagnostics AB

17.8. Corning Incorporated

17.9. Danaher Corporation

17.10. Denovix Inc.

17.11. F. Hoffmann-La Roche Ltd.

17.12. GMI OpCo, LLC

17.13. Luminex Corporation by DiaSorin S.p.A.

17.14. Merck KGaA

17.15. Molecular Devices, LLC

17.16. OLS OMNI Life Science GmbH & Co KG

17.17. Olympus Corporation

17.18. Revvity, Inc.

17.19. Sartorius AG

17.20. Sysmex Corporation

17.21. Tecan Trading AG

17.22. The Aligned Genetics

17.23. Thermo Fisher Scientific Inc.

17.24. Tip Biosystems Pte Ltd.

17.25. VWR International, LLC

For more information about this report visit https://www.researchandmarkets.com/r/63ixub

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.